Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

74.11
-0.1300-0.18%
Volume:240.89K
Turnover:17.83M
Market Cap:3.25B
PE:-68.47
High:75.08
Open:73.86
Low:73.52
Close:74.24
52wk High:85.25
52wk Low:48.20
Shares:43.88M
Float Shares:32.68M
Volume Ratio:0.51
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.38
PE(LYR):-46.61

Loading ...

Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 07, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report